Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
2.610
-0.640 (-19.69%)
At close: Mar 11, 2025, 4:00 PM
2.740
+0.130 (4.98%)
After-hours: Mar 11, 2025, 7:09 PM EST
Company Description
Medicus Pharma Ltd., a biotech/life sciences company, focuses on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers.
It is developing SkinJect with an indication for basal cell carcinoma. The company is headquartered in Toronto, Canada.
Medicus Pharma Ltd.
| Country | Canada |
| Founded | 2008 |
| Industry | Other |
| CEO | Raza Bokhari |
Contact Details
Address: One First Canadian Place, Suite 3400 Toronto, ON M5X 1A4 Canada | |
| Phone | 610-636-0184 |
| Website | medicuspharma.com |
Stock Details
| Ticker Symbol | MDCX |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| CIK Code | 0001997296 |
| ISIN Number | CA58471K2020 |
| Employer ID | 98-1778211 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Raza Bokhari | Chief Executive Officer |
| James Quinlan | Chief Financial Officer |
| Viktoriia Slepeniuk | Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 11, 2025 | 424B3 | Prospectus |
| Mar 11, 2025 | 8-K | Current Report |
| Mar 7, 2025 | 253G1 | Filing |
| Mar 6, 2025 | QUALIF | Filing |
| Feb 28, 2025 | 1-A/A | Filing |
| Feb 14, 2025 | F-X | Filing |
| Feb 14, 2025 | 1-A | Filing |
| Feb 13, 2025 | SCHEDULE 13G | Filing |
| Feb 11, 2025 | 8-K | Current Report |
| Feb 10, 2025 | SCHEDULE 13G | Filing |